Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma

Abstract Introduction : Glioma is one of the most aggressive human tumors; however, little is known about its genetic risk factors. The role of heredity is likely to be explained by combinations of common low-risk variants. Previous studies have indicated that more than 100 single nucleotide polymor...

Full description

Saved in:
Bibliographic Details
Published inCancer epidemiology Vol. 36; no. 3; pp. 283 - 287
Main Authors Li, Shanqu, Jin, Tianbo, Zhang, Jiayi, Lou, Huiling, Yang, Bo, Li, Yang, Chen, Chao, Zhang, Yongsheng
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.06.2012
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Introduction : Glioma is one of the most aggressive human tumors; however, little is known about its genetic risk factors. The role of heredity is likely to be explained by combinations of common low-risk variants. Previous studies have indicated that more than 100 single nucleotide polymorphisms (SNPs) are associated with the risk of glioma. Methods : To further investigate how and to what extent these SNPs contribute to glioma susceptibility in a Chinese population, we analyzed 43 SNPs of 226 glioma patients and 254 normal people in order to evaluate the associations between SNPs and the risk of glioma. Results : Overall, we found three protective alleles for glioma in patients: the allele “G” of rs1801275 in the IL4R gene by allele model (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.50–0.99; P = 0.04) and dominant model (OR, 0.67; 95% CI, 0.46–0.99; P = 0.04) analysis respectively, the allele “T” of rs17748 in the TREH gene by recessive model (OR, 0.48; 95% CI, 0.23–1.01; P = 0.05) analysis, and the allele “G” of rs6470745 in CCDC26 gene by recessive model (OR, 0.48; 95% CI, 0.26–0.89; P = 0.02) analysis. Conclusion : This study provides evidence for three glioma susceptibility genes – TREH, IL4R and CCDC26 – in a Chinese population; this may shed light on molecular markers of glioma susceptibility and could therefore be used as a diagnostic and prognostic marker for glioma patients in clinical study.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1877-7821
1877-783X
DOI:10.1016/j.canep.2011.12.011